Related Experiment Videos
[Typology of the hyperlipoproteinemias in ischemic heart disease]
Insights
A study of 227 patients with ischemic heart disease found high rates of hyperlipoproteinemia, particularly Type II and Type IV. These lipid disorders often persisted without spontaneous normalization.
Area of Science:
- Cardiology
- Metabolic Disorders
- Lipidology
Context:
- Ischemic heart disease (IHD) is a significant global health concern.
- Lipid metabolism abnormalities are key contributors to IHD pathogenesis.
- Understanding the prevalence of specific hyperlipoproteinemia types in IHD patients is crucial for risk stratification.
Purpose:
- To investigate the prevalence of hypercholesterolemia, hypertriglyceridemia, and various hyperlipoproteinemia types in patients with ischemic heart disease.
- To identify the most common types of hyperlipoproteinemia in this cohort.
- To explore gender-based differences in hyperlipoproteinemia prevalence.
Summary:
- A cohort of 227 ischemic heart disease patients was analyzed.
- Prevalence rates included: hypercholesterolemia (72%), hypertriglyceridemia (48%), and hyperlipoproteinemia (82%).
- Type II hyperlipoproteinemia was most frequent (59%), followed by Type IV (21%). Type IV was more common in men than women. Women more frequently exhibited normal lipoprotein levels. No spontaneous normalization was observed.
Impact:
- This study highlights the high burden of dyslipidemia in ischemic heart disease patients.
- Findings underscore the need for targeted lipid management strategies in IHD.
- The observed gender disparity in Type IV hyperlipoproteinemia warrants further investigation.
Abstract:
A total of 227 patients with ischaemic heart disease were examined. Hypercholesterolemia was revealed in 72 percent, hypertriglyceridemia--in 48 percent, and various types of hyperlipoproteinemia--in 82 percent. Type II hyperlipoproteinemia was seen most often (59 percent), type IV in 21 percent. Hyperlipoproteinemia of Type IV was found in men twice as often as in women (29 and 13 percent respectively). Women had normal levels of blood serum lipoproteins 1.5 times more often. No spontaneous normalization of hyperlopoproteinemia was noted.